Santen Pharmaceutical Co., Ltd. (4536.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 584.97B |
| Enterprise Value | 504.1B |
| P/E Ratio | 18.86 |
| PEG Ratio | 1.95 |
| Price/Sales Ratio | 2.37 |
| Price/Book Ratio | 2.35 |
| Enterprise/Revenue | 2.1 |
| Enterprise/EBITDA | 9.01 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 291.62B |
| Revenue/Share | 897.25 |
| Gross Profit | 160.97B |
| EBITDA | 67.79B |
| Net Income | 37.37B |
| Diluted EPS | 113.8 |
Balance Sheet
| Total Cash | 80.88B |
| Total Cash/Share | 248.83 |
| Total Debt | 34.75B |
| Total Debt/Equity | 0 |
| Current Ratio | 2.6 |
| Book Value Per Share | 910.77 |
Price History
| 52-Week Change | 30.8 |
| 52-Week High | 2,254 |
| 52-Week Low | 1,458 |
| Moving Average 50 Days | 1,929.53 |
| Moving Average 200 Days | 1,725.98 |
Statistics
| Average Volume | 1.17M |
| Shares Outstanding | 321.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 38 |
| Trailing Annual Dividend Yield | 1.77 |
| Payout Ratio | 0.34 |
| Last Split Factor | 5:1 |
| Last Split Date | March 27, 2015 |
AD
